- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Tower Semiconductor Posts Upbeat Earnings, Joins Nutex Health, Kornit Digital, Tencent Music Entertainment And Other Big Stocks Moving Higher On Wednesday | 2 | Benzinga.com | ||
| Mi | Nutex Health GAAP EPS of $2.56 beats by $1.68, revenue of $211.8M beats by $80.7M | 1 | Seeking Alpha | ||
| NUTEX HEALTH Aktie jetzt für 0€ handeln | |||||
| Di | Nutex Health, Inc.: Nutex Health Reports First Quarter 2025 Financial Results | 74 | PR Newswire | TOTAL REVENUE OF $211.8 MILLION VERSUS $67.5 MILLION IN Q1 2024, AN INCREASE OF 213.8%
NET INCOME ATTRIBUTABLE TO NUTEX HEALTH INC. OF $14.6 MILLION VERSUS NET... ► Artikel lesen | |
| Di | Nutex Health, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| Di | Nutex Health, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| Mo | Earnings Preview For Nutex Health | 2 | Benzinga.com | ||
| 30.04. | Nutex Health, Inc. - 10-K/A, Annual Report | - | SEC Filings | ||
| 25.04. | Nutex Health, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 22.04. | Nutex Health Inc. (NUTX): Among Most Expensive Stocks Insiders Are Buying After Trump's Tariff Rollout | 4 | Insider Monkey | ||
| 16.04. | Nutex Health files prospectus for secondary offering | 2 | Seeking Alpha | ||
| 09.04. | Benchmark raises Nutex Health stock price target to $150 | 1 | Investing.com | ||
| 09.04. | Nutex Health Is a Rare, Undervalued Winner Amidst Market Turmoil | 4 | Barchart.com | ||
| 03.04. | Nutex Health, Inc. (NASDAQ:NUTX) Q4 2024 Earnings Call Transcript | 1 | Insider Monkey | ||
| 01.04. | Benchmark maintains Nutex Health stock Buy rating, $60 target | 2 | Investing.com | ||
| 31.03. | Nutex Health GAAP EPS of $11.12, revenue of $257.62M | 2 | Seeking Alpha | ||
| 31.03. | Nutex Health, Inc.: Nutex Health Reports Fourth Quarter And Full Year 2024 Financial Results | 162 | PR Newswire | FULL YEAR 2024 HIGHLIGHTS:
TOTAL REVENUE OF $479.9 MILLION VERSUS $247.6 MILLION IN 2023, AN INCREASE OF 93.8%
NET INCOME OF $52.2 MILLION VERSUS NET LOSS OF... ► Artikel lesen | |
| 31.03. | Nutex Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 31.03. | Nutex Health, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| 28.03. | Exploring Nutex Health's Earnings Expectations | 5 | Benzinga.com | ||
| 26.03. | Earnings Preview: Nutex Health | 1 | Benzinga.com |
Seite:
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 258,30 | -6,35 % | UnitedHealth Group-Aktie leicht im Minus (338,6583 €) | Im US-amerikanischen Wertpapierhandel liegt die Aktie der UnitedHealth Group gegenwärtig im Minus. Die Aktie notiert derzeit bei 381,59 US-Dollar. Die UnitedHealth Group-Aktie verzeichnet aktuell ein... ► Artikel lesen | |
| INCANNEX HEALTHCARE | 0,671 | 0,00 % | Incannex Healthcare (IXHL) Stock Soars Over 800%: What's Going On? | ||
| FRESENIUS | 41,910 | +0,34 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 45 auf 50 Euro angehoben und die Einstufung auf "Buy" belassen. Nach dem starken Jahresstart der Aktie hätten... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 23,480 | +1,03 % | IPO Stock Of The Week: Health Care Leader BrightSpring Poised To Hit New Buy Point | ||
| ALIGNMENT HEALTHCARE | 14,910 | 0,00 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
| GENEDX | 59,51 | 0,00 % | GeneDx Holdings stock trades higher as upgraded at Jefferies | ||
| SIEMENS HEALTHINEERS | 47,890 | -0,54 % | GOLDMAN SACHS stuft Siemens Healthineers auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 60 auf 56 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Richard Felton passte... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 54,75 | +3,22 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HIMS & HERS HEALTH | 53,22 | -2,81 % | Hims & Hers Stock Pulls Back After Strong Q1 Earnings, 115% Gain Over Past Month | ||
| BASEL MEDICAL GROUP | 1,640 | 0,00 % | Basel Medical Group Ltd: Basel Medical Group Completes Acquisition of Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia | Singapore, April 30, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL), today announced the closing of the acquisition of Bethesda Medical Pte. Ltd., a leading Singapore-based healthcare... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 5,820 | -0,94 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2025 Outlook | First Quarter Revenue was $559.2 million, a 14.0% increase over the prior year period Gross margin increased 25.9% to $183.6 million compared to Q1 2024 First Quarter Net income was $5.2 million compared... ► Artikel lesen | |
| PROGYNY | 21,860 | 0,00 % | Progyny erweitert Medizinischen Beirat um zwei renommierte Ärztinnen | ||
| LIFEMD | 9,560 | 0,00 % | LifeMD, Inc.: LifeMD Reports Fourth Quarter 2024 Results | Consolidated revenues increased 43% year-over-year to $64.3 million with telehealth revenue up 60%Adjusted EBITDA increased 78% to $9.0 millionTelehealth adjusted EBITDA increased 396% to $5.9 millionFull-year... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 50,26 | +0,52 % | Fresenius Medical Care: Analysten pessimistisch - Die Kasse klingelt! | ||
| ATRICURE | 32,220 | +2,35 % | AtriCure Q1 2025 presentation: Revenue up 13.6%, raises full-year guidance |
NUTEX HEALTH INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +32,68 (+25,95 %) liegt der Kurs bei 158,61 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NUTEX HEALTH INC finden Sie auf Wallstreet Online.